Clinical trial / 2008
In a crossover trial, ANP infusion reduced postprandial blood pressure while increasing lipolysis, lipid oxidation rates, and energy expenditure after a meal.
Twelve men received an infusion of human ANP (25 ng/kg/min) or placebo before, during, and 2 hours after a standardized high-fat test meal in a randomized, double-blind, crossover study. ANP infusion decreased mean arterial blood pressure by 4 mmHg during the postprandial phase compared with placebo (P < 0.01). ANP also induced lipolysis systemically (P < 0.05) and locally in subcutaneous abdominal adipose tissue (P < 0.0001), resulting in a 50% increase in venous glycerol (P < 0.01) and free fatty acid concentrations (P < 0.05). Furthermore, ANP led to a 15% increase in lipid oxidation rates and a substantial increase in postprandial energy expenditure (both P < 0.05 vs. placebo).
- Study type
- Randomized, double-blind, crossover trial
- Who was studied
- 12 men (age 32 +/- 0.8 years, BMI 23.3 +/- 0.4 kg/m2)
- What was measured
- Mean arterial blood pressure, lipolysis, free fatty acids, lipid oxidation rates, and postprandial energy expenditure
THE PAPER
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, Berlan M, Marques MA, Sweep FC, Luft FC, Lafontan M, Jordan J. Diabetes, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.